Murine stromal cells counteract the loss of long-term culture- initiating cell potential induced by cytokines in CD34+CD38(low/neg) human bone marrow cells

Blood

Volumn 94, Issue 2, 1999, Pages 529-538

  Bennaceur Griscelli, Annelise ^a   Tourino, Cristina ^a   Izac, Brigitte ^a   Vainchenker, William ^a   Coulombel, Laure ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CYTOKINE; DIACLONE; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA CELL;

EID: 0033566322     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.2.529.414k21_529_538     Document Type: Article

References (68)

1. Wineman J, Moore K, Lemischka I, Muller-Sieburg C: Functional heterogeneity of the hematopoietic microenvironment: Rare stromal elements maintain long-term repopulating stem cells. Blood 87:4082, 1996
2. Moore KA, Ema H, Lemischka IR: In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood 89:4337, 1997
3. Fraser CC, Szilvassy SJ, Eaves CJ, Humphries RK: Proliferation of totipotent hematopoietic stem cells in vitro with retention of long-term competitive in vivo reconstituting ability. Proc Natl Acad Sci USA 89:1968, 1992
4. Coulombel L, Eaves AC, Eaves CJ: Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood 62:291, 1983
5. Dexter TM, Allen TD, Lajtha LG: Conditions controlling the proliferation of hemopoietic stem cells in vitro. J Cell Physiol 91:335, 1977
6. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM: Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74:1563, 1989
7. Hao QL, Thieman FT, Petersen D, Smogorzewska E, Crooks GM: Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood 88:3306, 1996
8. Ploemacher RE, van der Sluijs JP, van Beurden CA, Baert MR, Chan PL: Use of limiting dilution type long term marrow cultures in frequency analysis of marrow-repopulating and spleen-colony-forming hematopoietic stem cells in the mouse. Blood 78:2527, 1991
9. Breems DA, Blokland EA, Siebel KE, Mayen AE, Engels LJ, Ploemacher RE: Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells. Blood 91:111, 1998
10. - long-term culture-initiating cells. Blood 84:4116, 1994
11. Sutherland HJ, Eaves CJ, Lansdorp PM, Thacker JD, Hogge DE: Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 78:666, 1991
12. Thiemann FT, Moore KA, Smogorzewska EM, Lemischka IR, Crooks GM: The murine stromal cell line AFT024 acts specifically on human CD34+CD38-progenitors to maintain primitive function and immunophenotype in vitro. Exp Hematol 26:612, 1998
13. - progenitor cells from human cord blood generate B lymphocytes and granulocytes. Blood 89:3554, 1997
14. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B: Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89:2804, 1992
15. Verfaillie C, Miller J: A novel single-cell proliferation assay shows that long-term culture-initiating cell (LTC-IC) maintenance over time results from the extensive proliferation of a small fraction of LTC-IC. Blood 86:2137, 1995
16. Young J, Varma A, DiGiusto D, Backer M: Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood 87:545, 1996
17. - progenitor cells in long-term cultures and semisolid assays. Blood 81:2916, 1993
18. Hurley R, McCarthy JB, Verfaillie CM: Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 96:511, 1995
19. Verfaillie C, Catanzano P: Direct contact with stroma inhibits proliferation of human long-term culture initiating cells. Leukemia 10:498, 1996
20. Gordon MY, Lewis JL, Marley SB, Grand FH, Goldman JM: Stromal cells negatively regulate primitive haematopoietic progenitor cell activation via a phosphatidylinositol-anchored cell adhesion/signalling mechanism. Br J Haematol 96:647, 1998
21. Moore MAS: Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 78:1, 1991
22. Cashman JD, Eaves AC, Raines EW, Ross R, Eaves CJ: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGFβ. Blood 75:96, 1990
23. Hogge DE, Lansdorp PE, Reid D, Gerhard B, Eaves CJ: Enhanced detection, maintenance, and differentiation of primitive hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor. Blood 88:3765, 1996
24. Koller MR, Palsson MA, Manchel I, Palsson B: Long-term culture initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects. Blood 86:1784, 1995
25. Lyman SD, Jacobsen SE: c-kit ligand and flt3 ligand: Stem/ progenitor cell factors with overlapping yet distinct activities. Blood 91:1101, 1998
26. Luens KM, Travis MA, Chen BP, Hill BL, Scollay R, Murray LJ: Thrombopoietin, Kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thyl+Lin- cells with preserved ability to engraft SCID-hu bone. Blood 91:1206, 1998
27. Ramsfjell V, Borge OJ, Cui L, Jacobsen SE: Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+CD38-) human bone marrow progenitor cells. J Immunol 158:5169, 1997
28. Petzer A, Eaves C, Barnett M, Eaves A: Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia. Blood 90:64, 1997
29. Shah AJ, Smogorzweska E, Hannun C, Crooks GM: FLT3 ligand induces proliferation of quiescent human bone marrow CD34+CD38-cells and maintain progenitor cells in vitro. Blood 87:3563, 1995
30. Veiby OP, Jacobsen FW, Cui L, Lyman SD, Jacobsen SE: The FLT3-1 promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. J Immunol 157:2953, 1996
31. Young JC, Bruno E, Luens KM, Wu S, Backer M, Murray LJ: Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin- primitive progenitor cells. Blood 88:1619, 1996
32. Zandstra P, Conneally E, Petzer A, Piret J, Eaves C: Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA 94:4698, 1997
33. Conneally E, Cashman J, Petzer A, Eaves C: Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci USA 94:9836, 1997
34. Miller CL, Eaves CJ: Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. Proc Natl Acad Sci USA 94:13648, 1998
35. Sekhar M, Yu JM, Soma T, Dunbar CE: Murine long-term repopulating ability is compromised by ex vivo culture in serum free medium despite preservation of committed progenitors. J Hematoth 6:543, 1997
36. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ: Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11 and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87:30, 1996
37. Hornung RL, Longo DL: Hematopoietic stem cell depletion by restorative growth factor regimens during repeated high dose cyclophosphamide therapy. Blood 80:77, 1992
38. Van Os R, Robinson S, Sheridan T, Mislow JM, Dawes D, Mauch PM: Granulocyte colony-stimulating factor enhances bone marrow stem cell damage caused by repeated administration of cytotoxic agents. Blood 92:1950, 1998
39. Itoh K, Tezuka H, Sakoda H, Konno M, Nagata K, Uchiyama T, Uchino H, Mori KJ: Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp Hematol 17:145, 1989
40. Debili N, Coulombel L, Croisille L, Katz A, Breton-Gorius J, Vainchenker W: Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood 88:1284, 1996
41. Ponchio L, Conneally E, Eaves C: Quantitation of the quiescent fraction of long term culture-initiating cells in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro. Blood 86:3314, 1995
42. Sutherland HJ, Lansdorp PM, Henkelman DH, Eaves AC, Eaves CJ: Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 87:3584, 1990
43. Petzer A, Zandstra P, Piret J, Eaves C: Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J Exp Med 183:2551, 1996
44. Jordan CT, Yamasaki G, Minamoto D: High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoeitic cell populations. Exp Hematol 24:1347, 1996
45. Siminovitch L, McCulloch EA, Till JE: The distribution of colony-forming cells among spleen colonies. J Cell Physiol 62:327, 1963
46. Osawa M, Hanada K, Hamada H, Nakauchi H: Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273:242, 1996
47. Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M: Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol 26:353, 1998
48. Spangrude GJ, Brooks DM, Tumas DB: Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: In vivo expansion of stem cell phenotype but not function. Blood 85:1006, 1995
49. Rebel VI, Dragowska W, Eaves CJ, Humphries RK, Lansdorp PM: Amplification of Sca-1+Lin-WGA+ cells in serum-free cultures containing steel factor, interleukin-6 and erythropoietin with maintenance of cells with long-term in vivo reconstituting potential. Blood 83:128, 1994
50. Traycoff CM, Kasak ST, Grigsby S, Srour ER: Evaluation of expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood 82:2059, 1995
51. Jacobsen F, Stokke T, Jacobsen S: Transforming growth factor-β potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood 86:2957, 1995
52. Brummendorf TH, Dragowska W, Zijlmans MJ, Thornbury G, Lansdorp P: Asymetric cell dvisions sustain long-term hematopoiesis from single-sorted human fetal liver cells. J Exp Med 188:1117, 1998
53. - cell production in vitro. Br J Haematol 98:528, 1997
54. Metcalf D: Lineage commitment and maturation in hematopoietic cells: The case for extrinsic regulation. Blood 92:345, 1998
55. Petzer A, Hogge D, Landsdorp P, Reid D, Eaves C: Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 93:1470, 1996
56. Brandt JE, Galy AH, Luens KM, Travis M, Young J, Tong J, Chen S, Davis TA, Lee KP, Chen BP, Tushinski R, Hoffman R: Bone marrow repopulation by human bone marrow stem cells after long-term expansion culture on a porcine endothelial cell line. Exp Hematol 26:950, 1998
57. Soma T, Mei J, Dunbar CE: Maintenance of murine long-term repopulating stem cells in ex-vivo culture is affected by modulation of transforming growth factor-β but not macrophage inflammatory protein-1α activities. Blood 87:4561, 1998
58. Sitnicka E, Ruscetti FW, Priestley GV, Wolf NS, Bartelmez SH: Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood 88:82, 1996
59. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA, Ruoslahti E: Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302:527, 1994
60. Mitjavila MT, Filippi MD, Cohen-Solal K, Le Pesteur F, Vainchenker W, Sainteny F: The Mpl-ligand is involved in the growth-promoting activity of the murine stromal cell line MS-5 on ES cell-derived hematopoiesis. Exp Hematol 26:124, 1998
61. Miyazawa K, Williams DA, Gotoh A, Nishimaki J, Broxmeyer HE, Toyama K: Membrane-bound steel factor induces more persistent tyrosine-kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood 85:641, 1995
62. Gupta P, McCarthy J, Verfaillie C: Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-iniating cells. Blood 87:3229, 1996
63. Otsuka T, Thacker JD, Eaves CJ, Hogge DE: Differential effects of microenvironmentally presented interleukin 3 versus soluble growth factor on primitive human hematopoietic cells. J Clin Invest 88:417, 1991
64. Clark E, Brugge J: Integrins and signal transduction pathways: the road taken. Science 268:233, 1995
65. Milner LA, Bigas A, Kopan R, Brasheim-Stein C, Black M, Bernstein ID, Martin DI: Inhibition of granulocytic differentiation by mNotchl. Proc Natl Acad Sci USA 93:13014, 1998
66. Li L, Milner LA, Deng Y, Iwata M, Banta A, Graf L, Marcovina S, Friedman C, Trask BJ, Hood L, Torok-Storb B: The human homolog of rat jagged 1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch 1. Immunity 8:43, 1998
67. Pflumio F, Izac B, Katz A, Shultz L, Vainchenker W, Coulombel L: Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 88:3731, 1996
68. + cord blood cells. J Exp Med (in press)